Intracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trial
机构:[1]National Clinical Research Centre for Obstetrical and Gynaecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, China.[2]Research Centre for Clinical Epidemiology, Peking University Third Hospital, Beijing, China.[3]Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.浙江大学医学院附属妇产科医院[4]General Hospital of Ningxia Medical University, Yinchuan, China.[5]The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.中山大学附属第六医院[6]The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.[7]The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.[8]First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院[9]First Affiliated Hospital of Anhui Medical University, Hefei, China.[10]The Second Hospital of Hebei Medical University, Shijiazhuang, China.[11]Haidian Maternal and Child Health Hospital, Beijing, China.[12]Department of Obstetrics and Gynaecology, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.[13]Obstetrics and Gynaecology Hospital, Ministry of Education Key Laboratory of Reproductive Genetics, School of Medicine, Zhejiang University, Hangzhou, China.浙江大学医学院附属妇产科医院[14]National Clinical Research Centre for Obstetrical and Gynaecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, China.
National Natural Science Foundation of China (82288102), the National Key Research and Development Program (2022YFC2702500), the Beijing Municipal Science & Technology Commission (Z191100006619085), and the Peking University Third Hospital (BYSYZD2019007, BYSYDL2022001).
第一作者机构:[1]National Clinical Research Centre for Obstetrical and Gynaecological Diseases, State Key Laboratory of Female Fertility Promotion, Ministry of Education Key Laboratory of Assisted Reproduction, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wang Yuanyuan,Li Rong,Yang Rui,et al.Intracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trial[J].LANCET.2024,403(10430):924-934.doi:10.1016/S0140-6736(23)02416-9.
APA:
Wang Yuanyuan,Li Rong,Yang Rui,Zheng Danni,Zeng Lin...&Qiao Jie.(2024).Intracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trial.LANCET,403,(10430)
MLA:
Wang Yuanyuan,et al."Intracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trial".LANCET 403..10430(2024):924-934